| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 100.39B | 102.68B | 101.27B | 94.34B | 79.64B | 55.86B |
| Gross Profit | 17.11B | 18.26B | 18.45B | 17.97B | 19.10B | 14.96B |
| EBITDA | 8.81B | 10.17B | 13.24B | 12.02B | 13.14B | 10.64B |
| Net Income | 3.03B | 4.09B | 5.22B | 4.73B | 6.40B | 5.15B |
Balance Sheet | ||||||
| Total Assets | 138.49B | 132.48B | 137.87B | 112.05B | 106.14B | 93.87B |
| Cash, Cash Equivalents and Short-Term Investments | 11.24B | 7.53B | 10.81B | 6.44B | 10.09B | 13.45B |
| Total Debt | 26.71B | 23.52B | 27.12B | 22.97B | 12.01B | 11.51B |
| Total Liabilities | 71.28B | 68.51B | 74.49B | 59.76B | 52.10B | 47.00B |
| Stockholders Equity | 43.39B | 41.17B | 40.77B | 39.33B | 41.26B | 36.27B |
Cash Flow | ||||||
| Free Cash Flow | 1.50B | 2.80B | 4.51B | -2.14B | 2.85B | 4.24B |
| Operating Cash Flow | 5.89B | 7.00B | 10.16B | 4.28B | 8.80B | 8.95B |
| Investing Cash Flow | -1.38B | -2.23B | -4.53B | -15.13B | -11.14B | -7.20B |
| Financing Cash Flow | -5.71B | -7.43B | -1.96B | 7.62B | -3.35B | -2.10B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$71.93B | 12.01 | 12.60% | 4.30% | -3.19% | -2.68% | |
67 Neutral | HK$43.35B | 14.60 | 8.10% | 4.43% | -4.37% | -41.14% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
63 Neutral | HK$39.66B | 7.70 | 5.14% | 6.44% | -2.28% | -9.61% | |
59 Neutral | HK$2.84B | 5.95 | 4.85% | 4.94% | 7.55% | -32.06% | |
56 Neutral | HK$12.67B | 8.67 | 6.35% | 6.38% | 3.86% | 30.34% | |
48 Neutral | HK$7.39B | 11.48 | 2.04% | 0.71% | -7.82% | -38.06% |